Julphar appoints a new CEO to drive operational shift and support growth

0
66


(MENAFN – Alghad Newspaper) The newly appointed CEO pledges to advance the new strategic focus of the regional drug giant

Ras Al-Khaimah (United Arab Emirates) – Gulf Pharmaceutical Industries, Julphar, one of the largest pharmaceutical manufacturing companies in the Middle East and Africa, has appointed Dr. Issam Farouk as CEO, in light of the company’s pioneering transformation program in the Middle East and other areas. Regions.

Dr. will lead Issam, who has more than 27 years of experience, is the growth and development of Julphar Company through its continuous commitment to raise the level of its facilities, operations, practices and infrastructure in a way that ensures the continuity of the company with durability during the year 2020 and the coming years. Dr. Issam will contribute to establishing Julphar’s position in the market as a leading pharmaceutical company in the region, by working to complete its mission to provide high-quality solutions and promote the health of people at the regional and global levels.

On his part, His Highness Sheikh Saqr bin Humaid Al Qasimi, Chairman of Julphar, said: “Dr. Essam’s proven track record in the pharmaceutical industry, in addition to his extensive experience in the pharmaceutical industry in both established and emerging markets, is evidence of his leadership in pioneering transformations in Business, in addition to its strategic planning and ensuring the stages of implementing strategies, and its ability to manage a diverse organization and push it to success and enhance its business in difficult environments would ensure the huge impact of Julphar in the 50 markets where we operate throughout the world. ”

Before his appointment to Julphar, Dr. Issam is the CEO of the “Canadian” pharmaceutical products company, taking over the management of the company since its inception in 2006. Through his exceptional leadership, the company has witnessed exceptional growth as it has become the second largest pharmaceutical company in Algeria and North Africa. After that, he held the position of CEO of the group, “MS Pharma” for seven years, as the transformation brought about by the company made it one of the five largest leading pharmaceutical companies in the Middle East and North Africa. Dr. Issam holds senior positions in many companies, including GlaxoSmithKline, Sanofi Aventis, T3A Pharma Group and Julphar Germany, thereby accumulating a wealth of valuable experiences across public and multinational business environments.

Dr. said. Issam Farooq, commenting on joining Julphar: “I am proud to join an organization located at the heart of the UAE, and still contributing to economic growth in Ras Al Khaimah and abroad. I look forward to working with a highly skilled team in the coming months, as we aim to continue to ensure production Quality medicines, along with value-added product innovation and healthcare solutions that transform the lives of those who need them most. I am fully committed to restoring Julphar’s position as a regionally leading pharmaceutical industry within three years. ”

Dr. Essam holds a Bachelor’s degree in Pharmacy from the University of “Zagazig”, in addition to obtaining a master’s degree in Total Quality Management and Operations Management from the American University in Cairo and the American Quality Association.

MENAFN0604202000720000ID1099975231





LEAVE A REPLY

Please enter your comment!
Please enter your name here